Adenoviral Vector Monotherapy or Combination With Chemotherapy in Subjects With Recurrent/Metastatic Breast Cancer.
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer Nos Metastatic Recurrent
Interventions: GENETIC: Ad-RTS-hIL-12 and Veledimex|DRUG: Palifosfamide
Sponsor: Alaunos Therapeutics